Literature DB >> 32229578

LDB1 Enforces Stability on Direct and Indirect Oncoprotein Partners in Leukemia.

Justin H Layer1, Michael Christy1, Lindsey Placek2, Derya Unutmaz2, Yan Guo3, Utpal P Davé4,5.   

Abstract

The LMO2/LDB1 macromolecular complex is critical in hematopoietic stem and progenitor cell specification and in the development of acute leukemia. This complex is comprised of core subunits of LMO2 and LDB1 as well as single-stranded DNA-binding protein (SSBP) cofactors and DNA-binding basic helix-loop-helix (bHLH) and GATA transcription factors. We analyzed the steady-state abundance and kinetic stability of LMO2 and its partners via Halo protein tagging in conjunction with variant proteins deficient in binding their respective direct protein partners. We discovered a hierarchy of protein stabilities (with half-lives in descending order) as follows: LDB1 > SSBP > LMO2 > TAL1. Importantly, LDB1 is a remarkably stable protein that confers enhanced stability upon direct and indirect partners, thereby nucleating the formation of the multisubunit protein complex. The data imply that free subunits are more rapidly degraded than those incorporated within the LMO2/LDB1 complex. Our studies provided significant insights into LMO2/LDB1 macromolecular protein complex assembly and stability, which has implications for understanding its role in blood cell formation and for therapeutically targeting this complex in human leukemias.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  LIM domain Only 2; LIM domain protein 1; hematopoietic stem cell; leukemia; multisubunit complex; protein degradation; protein turnover; pulse-chase

Year:  2020        PMID: 32229578      PMCID: PMC7261719          DOI: 10.1128/MCB.00652-19

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Architecture of the Mediator head module.

Authors:  Tsuyoshi Imasaki; Guillermo Calero; Gang Cai; Kuang-Lei Tsai; Kentaro Yamada; Francesco Cardelli; Hediye Erdjument-Bromage; Paul Tempst; Imre Berger; Guy Lorch Kornberg; Francisco J Asturias; Roger D Kornberg; Yuichiro Takagi
Journal:  Nature       Date:  2011-07-03       Impact factor: 49.962

Review 2.  Induced protein degradation: an emerging drug discovery paradigm.

Authors:  Ashton C Lai; Craig M Crews
Journal:  Nat Rev Drug Discov       Date:  2016-11-25       Impact factor: 84.694

3.  Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor.

Authors:  Wulan Deng; Jongjoo Lee; Hongxin Wang; Jeff Miller; Andreas Reik; Philip D Gregory; Ann Dean; Gerd A Blobel
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

4.  Systematic and quantitative assessment of the ubiquitin-modified proteome.

Authors:  Woong Kim; Eric J Bennett; Edward L Huttlin; Ailan Guo; Jing Li; Anthony Possemato; Mathew E Sowa; Ramin Rad; John Rush; Michael J Comb; J Wade Harper; Steven P Gygi
Journal:  Mol Cell       Date:  2011-09-08       Impact factor: 17.970

5.  Alg14 recruits Alg13 to the cytoplasmic face of the endoplasmic reticulum to form a novel bipartite UDP-N-acetylglucosamine transferase required for the second step of N-linked glycosylation.

Authors:  Xiao-Dong Gao; Hiroyuki Tachikawa; Takashi Sato; Yoshifumi Jigami; Neta Dean
Journal:  J Biol Chem       Date:  2005-08-12       Impact factor: 5.157

6.  A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein.

Authors:  K Breitschopf; E Bengal; T Ziv; A Admon; A Ciechanover
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

7.  Novel binding partners of Ldb1 are required for haematopoietic development.

Authors:  Natalia Meier; Sanja Krpic; Patrick Rodriguez; John Strouboulis; Maria Monti; Jeroen Krijgsveld; Martin Gering; Roger Patient; Arnd Hostert; Frank Grosveld
Journal:  Development       Date:  2006-11-15       Impact factor: 6.868

8.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

9.  Active site alanine mutations convert deubiquitinases into high-affinity ubiquitin-binding proteins.

Authors:  Marie E Morrow; Michael T Morgan; Marcello Clerici; Katerina Growkova; Ming Yan; David Komander; Titia K Sixma; Michal Simicek; Cynthia Wolberger
Journal:  EMBO Rep       Date:  2018-08-27       Impact factor: 8.807

10.  Role of LDB1 in the transition from chromatin looping to transcription activation.

Authors:  Ivan Krivega; Ryan K Dale; Ann Dean
Journal:  Genes Dev       Date:  2014-05-29       Impact factor: 11.361

View more
  3 in total

1.  Cytoplasmic LMO2-LDB1 Complex Activates STAT3 Signaling through Interaction with gp130-JAK in Glioma Stem Cells.

Authors:  Cheol Gyu Park; Sang-Hun Choi; Seon Yong Lee; Kiyoung Eun; Min Gi Park; Junseok Jang; Hyeon Ju Jeong; Seong Jin Kim; Sohee Jeong; Kanghun Lee; Hyunggee Kim
Journal:  Cells       Date:  2022-06-26       Impact factor: 7.666

2.  LIM-Domain-Binding Protein 1 Mediates Cell Proliferation and Drug Resistance in Colorectal Cancer.

Authors:  Mo Zhu; Baofei Jiang; Hao Zuo; Xiaopeng Wang; Hengfa Ge; Ziming Huang
Journal:  Front Surg       Date:  2022-01-06

Review 3.  E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia.

Authors:  Geoffrey Parriott; Barbara L Kee
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.